Urinary incontinence is a serious worldwide health problem. It can have a serious impact on the health status and overall quality of life of the patient. A national group of data shows that the incidence of urinary incontinence in women can be up to 46.5%. However, due to various reasons such as perceptions, only 24.5% of women with urinary incontinence have a tendency to seek medical attention. Many patients with urinary incontinence are curable, and some are even simple to treat, so it is our responsibility as health care workers to pay more attention to them. Stress urinary incontinence is one of the more common and simpler to treat. A survey in Beijing shows that: the incidence of female incontinence is 46.5%, of which 56% is stress incontinence. Many middle-aged and older women have the experience of.
Coughing, sneezing, laughing, exercise and other increases in abdominal pressure will occur when the phenomenon of uncontrollable, involuntary urine pants. In severe cases, this can limit daily activities and interfere with normal interactions. Some of the clearer factors associated with stress urinary incontinence are age, childbirth, pelvic organ prolapse, obesity, race and genetics. The high incidence of stress urinary incontinence is between 45 and 55 years of age. Age, childbirth, and obesity can lead to atrophy of connective tissue, relaxation of the pelvic floor muscles, and degeneration of the urethral sphincter, making it impossible for the urethral sphincter to close the urethra well when abdominal pressure increases, and thus urinary incontinence occurs. For lighter patients, pelvic floor muscle training (anal exercise) can be carried out to exercise the function of the urethral sphincter and improve urinary control; weight loss can also help reduce symptoms, and data show that for every 10% decrease in body weight, the number of incontinence can be reduced by 50%. The heavier patients can be treated with electrical stimulation, magnetic stimulation therapy, through repeated electrical and magnetic stimulation of the pelvic floor muscle, enhance the contraction of the pelvic floor muscle, improve urinary control ability. The representative drug is Midodrine Hydrochloride; Sernitine is an M-cholinergic receptor blocker.
It can inhibit the contraction of the detrusor muscle and is effective in reducing the symptoms of stress urinary incontinence. For those who need to undergo pelvic floor reconstruction surgery, such as those with poor results of non-surgical treatment, those with moderate or above stress incontinence that seriously affects their quality of life (inability to engage in their favorite sports, inability to work normally, needing pads every day, changing their lifestyle due to stress incontinence, staying away from society due to stress incontinence, etc.), those with high quality of life requirements, those with long-term leakage that leads to vulvar skin eczema, and those with pelvic organ prolapse. Surgical treatment should be chosen. The minimally invasive treatment of stress urinary incontinence, the tension-free transvaginal midurethral sling (TVT), started in 1996, has brought a new revolution in the treatment of stress urinary incontinence, and the entire procedure can be completed in about 20 minutes. The non-tension transvaginal mid-urethral sling (TVT) treatment for female stress urinary incontinence has a cure rate of over 90%. With its stable efficacy, minimal trauma and few complications, this procedure has quickly become widely accepted by doctors and patients after its application in the clinic.